↓ Skip to main content

Cost-Effectiveness Analyses of Osteoarthritis Oral Therapies: a Systematic Review

Overview of attention for article published in Applied Health Economics and Health Policy, November 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
72 Mendeley
Title
Cost-Effectiveness Analyses of Osteoarthritis Oral Therapies: a Systematic Review
Published in
Applied Health Economics and Health Policy, November 2013
DOI 10.1007/s40258-013-0061-x
Pubmed ID
Authors

Ronald C. Wielage, Julie A. Myers, Robert W. Klein, Michael Happich

Abstract

Cost-effectiveness analyses (CEAs) have been performed for oral non-disease-altering osteoarthritis (OA) treatments for well over a decade. During that period the methods for performing these analyses have evolved as pharmacoeconomic methods have advanced, new treatments have been introduced, and the knowledge of associated adverse events (AEs) has improved.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 1%
Unknown 71 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 21%
Researcher 9 13%
Student > Ph. D. Student 9 13%
Student > Doctoral Student 6 8%
Other 6 8%
Other 14 19%
Unknown 13 18%
Readers by discipline Count As %
Medicine and Dentistry 31 43%
Nursing and Health Professions 3 4%
Agricultural and Biological Sciences 3 4%
Psychology 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 13 18%
Unknown 16 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2017.
All research outputs
#7,191,499
of 22,729,647 outputs
Outputs from Applied Health Economics and Health Policy
#323
of 771 outputs
Outputs of similar age
#68,329
of 215,012 outputs
Outputs of similar age from Applied Health Economics and Health Policy
#4
of 12 outputs
Altmetric has tracked 22,729,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 771 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,012 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.